Department of Cell Biology, Harvard Medical School, 240 Longwood Ave., Boston, MA, 02115, USA.
Department of Pathology, Brigham & Women's Hospital, 75 Francis St, Boston, MA, 02115, USA.
Nat Commun. 2020 Apr 6;11(1):1711. doi: 10.1038/s41467-020-15548-7.
Recently, organoid technology has been used to generate a large repository of breast cancer organoids. Here we present an extensive evaluation of the ability of organoid culture technology to preserve complex stem/progenitor and differentiated cell types via long-term propagation of normal human mammary tissues. Basal/stem and luminal progenitor cells can differentiate in culture to generate mature basal and luminal cell types, including ER+ cells that have been challenging to maintain in culture. Cells associated with increased cancer risk can also be propagated. Single-cell analyses of matched organoid cultures and native tissues by mass cytometry for 38 markers provide a higher resolution representation of the multiple mammary epithelial cell types in the organoids, and demonstrate that protein expression patterns of the tissue of origin can be preserved in culture. These studies indicate that organoid cultures provide a valuable platform for studies of mammary differentiation, transformation, and breast cancer risk.
最近,类器官技术已被用于生成大量乳腺癌类器官库。在这里,我们通过长期培养正常人类乳腺组织,广泛评估了类器官培养技术在保存复杂的干细胞/祖细胞和分化细胞类型方面的能力。基底/干细胞和腔前体细胞可以在培养中分化,生成成熟的基底和腔细胞类型,包括在培养中难以维持的 ER+细胞。与癌症风险增加相关的细胞也可以被繁殖。通过质谱细胞术对 38 个标志物的匹配类器官培养物和天然组织进行单细胞分析,提供了类器官中多种乳腺上皮细胞类型的更高分辨率表示,并证明了组织起源的蛋白表达模式可以在培养中保存。这些研究表明,类器官培养物为乳腺分化、转化和乳腺癌风险的研究提供了一个有价值的平台。